Wire · opportunities
Automated Insulin Delivery in T2D: Latest System FDA Cleared
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 October 2026 · Fusion42 review
The FDA has cleared the twiist Automated Insulin Delivery (AID) System for adults with insulin-treated type 2 diabetes, showing improved glycemic control and safety in a pivotal trial. This system continuously adjusts basal insulin and integrates with certain continuous glucose monitors, expanding treatment options for this patient group.
This Wire brief sits within Fusion42's coverage of Digital Health, and 2 sources have reported it.
◆ ◆ The Wire takeaway
You now have regulatory backing to offer advanced insulin delivery with twiist, which adjusts basal doses precisely and integrates with top glucose monitors. This opens a door to move beyond traditional insulin regimens for adults with type 2 diabetes who need tighter control.
◆ Coverage
2 sources · 16 Oct 2026
◆ Related on Wire
◆ Topics